PHX — Pharmx Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- AU$29.93m
- AU$17.78m
- AU$6.13m
- 56
- 72
- 87
- 81
C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.33 | 2.32 | 6.48 | 5.76 | 12.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.81 | 5.53 | 2.41 | 2.63 | 2.6 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 9.19 | 9.84 | 10.4 | 8.59 | 22.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.731 | 1.23 | 0.791 | 0.603 | 0.047 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 15 | 19.2 | 31.3 | 30.8 | 36.5 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.28 | 5.48 | 6.39 | 5.11 | 12.3 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.48 | 5.98 | 8.42 | 7.57 | 14.3 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 9.56 | 13.2 | 22.9 | 23.2 | 22.2 |
Total Liabilities & Shareholders' Equity | 15 | 19.2 | 31.3 | 30.8 | 36.5 |
Total Common Shares Outstanding |